AB56-ASA1-AA2,26,2019
3. Prescription drugs imported under the program are pure, unadulterated,
20potent, and safe.
AB56-ASA1-AA2,26,2221
4. The prescription drug importation program is complying with the
22requirements of this subsection.
AB56-ASA1-AA2,26,2523
5. The prescription drug importation program under this section is adequately
24financed to support administrative functions of the program while generating
25significant cost savings to residents of the state.
AB56-ASA1-AA2,27,2
16. The prescription drug importation program under this section does not put
2residents of the state at a higher risk than if the program did not exist.
AB56-ASA1-AA2,27,43
7. The prescription drug importation program under this section provides and
4is projected to continue to provide substantial cost savings to residents of the state.
AB56-ASA1-AA2,27,7
5(2) Anticompetitive behavior. The department, in consultation with the
6attorney general, shall identify the potential for and monitor anticompetitive
7behavior in industries affected by a prescription drug importation program.
AB56-ASA1-AA2,27,18
8(3) Approval of program design; certification. No later than the first day of
9the 7th month beginning after the effective date of this subsection .... [LRB inserts
10date], the department shall submit to the joint committee on finance a report that
11includes the design of the prescription drug importation program in accordance with
12this section. The department may not submit the proposed prescription drug
13importation program to the federal department of health and human services unless
14the joint committee on finance approves the proposed prescription drug
15implementation program. Within 14 days of the date of approval by the joint
16committee on finance of the proposed prescription drug importation program, the
17department shall submit to the federal department of health and human services a
18request for certification of the approved prescription drug importation program.
AB56-ASA1-AA2,28,2
19(4) Implementation of certified program. After the federal department of
20health and human services certifies the prescription drug importation program
21submitted under sub. (3), the department shall begin implementation of the program
22and the program shall be fully operational by 180 days after the date of certification
23by the federal department of health and human services. The department shall do
24all of the following to implement the prescription drug importation program to the
1extent the action is in accordance with other state laws and the certification by the
2federal department of health and human services:
AB56-ASA1-AA2,28,53
(a) Become a licensed wholesale distributor, designate another state agency to
4become a licensed wholesale distributor, or contract with a licensed wholesale
5distributor.
AB56-ASA1-AA2,28,76
(b) Contract with one or more Canadian suppliers that meet the criteria in sub.
7(1) (c).
AB56-ASA1-AA2,28,118
(c) Create an outreach and marketing plan to communicate with and provide
9information to health plans and health insurance policies, employers, pharmacies,
10health care providers, and residents of the state on participating in the prescription
11drug importation program.
AB56-ASA1-AA2,28,1412
(d) Develop and implement a registration process for health plans and health
13insurance policies, pharmacies, and health care providers interested in participating
14in the prescription drug importation program.
AB56-ASA1-AA2,28,1615
(e) Create a publicly accessible source for listing prices of prescription drugs
16imported under the program.
AB56-ASA1-AA2,28,1917
(f) Create, publicize, and implement a method of communication to promptly
18answer questions from and address the needs of persons affected by the
19implementation of the program before the program is fully operational.
AB56-ASA1-AA2,28,2120
(g) Establish the audit functions under sub. (1) (n) with a timeline to complete
21each audit function every 2 years.
AB56-ASA1-AA2,28,2422
(h) Conduct any other activities determined by the department to be important
23to successful implementation of the prescription drug importation program under
24this section.
AB56-ASA1-AA2,29,2
1(5) Report. By January 1 and July 1 of each year, the department shall submit
2to the joint committee on finance a report including all of the following:
AB56-ASA1-AA2,29,43
(a) A list of prescription drugs included in the importation program under this
4section.
AB56-ASA1-AA2,29,75
(b) The number of pharmacies, health care providers, and health plans and
6health insurance policies participating in the prescription drug importation program
7under this section.
AB56-ASA1-AA2,29,128
(c) The estimated amount of savings to residents of the state, health plans and
9health insurance policies, and employers resulting from the implementation of the
10prescription drug importation program under this section reported from the date of
11the previous report under this subsection and from the date the program was fully
12operational.
AB56-ASA1-AA2,29,1413
(d) Findings of any audit functions under sub. (1) (n) completed since the date
14of the previous report under this subsection.”.
AB56-ASA1-AA2,29,2217
250.10
(1m) (b) Award in each fiscal year to qualified applicants grants totaling
18$25,000 no less than $50,000 for fluoride
supplements, $25,000 for a fluoride
19mouth-rinse program varnish and other evidence-based oral health activities,
20$700,000 for school-based preventive dental services, and
$120,000 for a
21school-based dental sealant program $100,000 for school-based restorative dental
22services.”.
AB56-ASA1-AA2,30,112
250.20
(3) From the appropriation account under s. 20.435 (1)
(kb) (cr), the
3department shall annually award grants for activities to improve the health status
4of economically disadvantaged minority group members. A person may apply, in the
5manner specified by the department, for a grant of up to $50,000 in each fiscal year
6to conduct these activities. An awardee of a grant under this subsection shall
7provide, for at least 50 percent of the grant amount, matching funds that may consist
8of funding or an in-kind contribution. An applicant that is not a federally qualified
9health center, as defined under
42 CFR 405.2401 (b) shall receive priority for grants
10awarded under this subsection.
An applicant that provides maternal and child
11health services shall receive priority for grants awarded under this subsection.
AB56-ASA1-AA2,30,1613
250.20
(4) From the appropriation account under s. 20.435 (1)
(kb) (cr), the
14department shall award a grant of up to $50,000 in each fiscal year to a private
15nonprofit corporation that applies, in the manner specified by the department, to
16conduct a public information campaign on minority health.”.